FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387599219> ?p ?o ?g. }

• W4387599219 abstract "Oral anticoagulants, including warfarin and direct oral anticoagulants, are the standard of care for thrombosis prevention and treatment; however, concerns of bleeding often dictate treatment decisions. Inhibition of the intrinsic coagulation system via factor XIa may allow for selective inhibition of the coagulation cascade without significantly impacting hemostasis after injury. Asundexian is an oral small molecule factor XIa inhibitor that, via this novel mechanism, may prove to be a safe and effective option compared with available anticoagulants. Early clinical data for asundexian was promising as a safer alternative to current therapies and prompted further analysis in certain patient populations at increased thrombotic risk. Currently, studies are ongoing to evaluate the safety and efficacy in stroke prevention in atrial fibrillation and in patients following an acute noncardioembolic ischemic stroke or high-risk transient ischemic attack.Current oral anticoagulants have been shown to be effective for treating and preventing different clotting conditions. The disadvantage associated with these agents is an increased risk of bleeding; thus, there is a need for safer alternatives. Asundexian is a new anticoagulant that has been studied in patients after a stroke, patients with abnormal heart rhythms and patients after a heart attack in three completed clinical trials and two that are currently ongoing. Asundexian works by blocking factor XI, which is necessary for clot formation. Asundexian appears to be a promising option for preventing and treating thrombotic conditions while potentially limiting the risk of bleeding as a result of its distinct mechanism of action. The following summary explains how asundexian works and highlights the key studies showing the effects of this medication." @default.
• W4387599219 created "2023-10-14" @default.
• W4387599219 creator A5091388658 @default.
• W4387599219 creator A5093055336 @default.
• W4387599219 creator A5093055337 @default.
• W4387599219 date "2023-10-13" @default.
• W4387599219 modified "2023-10-18" @default.
• W4387599219 title "Asundexian: an oral small molecule factor XIa inhibitor for the treatment of thrombotic disorders" @default.
• W4387599219 cites W1547546593 @default.
• W4387599219 cites W1551095964 @default.
• W4387599219 cites W1979338133 @default.
• W4387599219 cites W2115570439 @default.
• W4387599219 cites W2117677020 @default.
• W4387599219 cites W2126594141 @default.
• W4387599219 cites W2162508946 @default.
• W4387599219 cites W2338854794 @default.
• W4387599219 cites W2402689780 @default.
• W4387599219 cites W2803966697 @default.
• W4387599219 cites W3026746069 @default.
• W4387599219 cites W3081789922 @default.
• W4387599219 cites W3090209681 @default.
• W4387599219 cites W3176430801 @default.
• W4387599219 cites W3189369858 @default.
• W4387599219 cites W4205147589 @default.
• W4387599219 cites W4220704559 @default.
• W4387599219 cites W4223439574 @default.
• W4387599219 cites W4229447795 @default.
• W4387599219 cites W4255683973 @default.
• W4387599219 cites W4293372203 @default.
• W4387599219 cites W4293410865 @default.
• W4387599219 cites W4296902187 @default.
• W4387599219 cites W4311206284 @default.
• W4387599219 doi "https://doi.org/10.2217/fca-2023-0051" @default.
• W4387599219 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37830334" @default.
• W4387599219 hasPublicationYear "2023" @default.
• W4387599219 type Work @default.
• W4387599219 citedByCount "0" @default.
• W4387599219 crossrefType "journal-article" @default.
• W4387599219 hasAuthorship W4387599219A5091388658 @default.
• W4387599219 hasAuthorship W4387599219A5093055336 @default.
• W4387599219 hasAuthorship W4387599219A5093055337 @default.
• W4387599219 hasConcept C126322002 @default.
• W4387599219 hasConcept C127413603 @default.
• W4387599219 hasConcept C164705383 @default.
• W4387599219 hasConcept C177713679 @default.
• W4387599219 hasConcept C2776301958 @default.
• W4387599219 hasConcept C2776710957 @default.
• W4387599219 hasConcept C2778589496 @default.
• W4387599219 hasConcept C2778661090 @default.
• W4387599219 hasConcept C2778810321 @default.
• W4387599219 hasConcept C2779161974 @default.
• W4387599219 hasConcept C2780645631 @default.
• W4387599219 hasConcept C2780868729 @default.
• W4387599219 hasConcept C535046627 @default.
• W4387599219 hasConcept C71924100 @default.
• W4387599219 hasConcept C78519656 @default.
• W4387599219 hasConceptScore W4387599219C126322002 @default.
• W4387599219 hasConceptScore W4387599219C127413603 @default.
• W4387599219 hasConceptScore W4387599219C164705383 @default.
• W4387599219 hasConceptScore W4387599219C177713679 @default.
• W4387599219 hasConceptScore W4387599219C2776301958 @default.
• W4387599219 hasConceptScore W4387599219C2776710957 @default.
• W4387599219 hasConceptScore W4387599219C2778589496 @default.
• W4387599219 hasConceptScore W4387599219C2778661090 @default.
• W4387599219 hasConceptScore W4387599219C2778810321 @default.
• W4387599219 hasConceptScore W4387599219C2779161974 @default.
• W4387599219 hasConceptScore W4387599219C2780645631 @default.
• W4387599219 hasConceptScore W4387599219C2780868729 @default.
• W4387599219 hasConceptScore W4387599219C535046627 @default.
• W4387599219 hasConceptScore W4387599219C71924100 @default.
• W4387599219 hasConceptScore W4387599219C78519656 @default.
• W4387599219 hasLocation W43875992191 @default.
• W4387599219 hasLocation W43875992192 @default.
• W4387599219 hasOpenAccess W4387599219 @default.
• W4387599219 hasPrimaryLocation W43875992191 @default.
• W4387599219 hasRelatedWork W1977420807 @default.
• W4387599219 hasRelatedWork W2093259736 @default.
• W4387599219 hasRelatedWork W2134062404 @default.
• W4387599219 hasRelatedWork W2220556496 @default.
• W4387599219 hasRelatedWork W2287009094 @default.
• W4387599219 hasRelatedWork W2534592337 @default.
• W4387599219 hasRelatedWork W2554249818 @default.
• W4387599219 hasRelatedWork W2559512053 @default.
• W4387599219 hasRelatedWork W3016737606 @default.
• W4387599219 hasRelatedWork W4210354924 @default.
• W4387599219 isParatext "false" @default.
• W4387599219 isRetracted "false" @default.
• W4387599219 workType "article" @default.